ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Association between Early Progression in Chronic Kidney Disease Stage Following Liver Transplantation and Graft Survival

W. Irish, P. Massa, M. Tran, P. Bernhardt, J. Ricci

CTI Clinical Trial and Consulting Svcs, Raleigh
Novartis Pharmaceuticals Corporation, East Hanover
Novartis Pharma AG, Basel, Switzerland
Wellmera AG, Basel, Switzerland

Meeting: 2013 American Transplant Congress

Abstract number: D1681

Introduction: Renal dysfunction before and after liver transplantation is a significant predictor of graft survival (GS). This study aims to characterize the relationship between early changes in renal function (RF) and GS post-liver transplantation.

Methods: Adult patients in the OPTN/UNOS database who received a primary liver transplant between 2002 & 2011 due to HCV, alcoholic cirrhosis and HCC were eligible. RF, measured by eGFR, at time of transplant and at 12 months (M) was categorized by CKD stage. Impact of a shift in CKD stage on the risk of graft failure (GF) was assessed using Cox hazards model with left truncation.

Results: A total of 28,014 patients with eGFR data at time of transplant were included (mean age 54 years; 71% male; 4-year median follow-up). Of these, 41% were transplanted for HCV cirrhosis, 29% for alcoholic cirrhosis and 30% for HCC. At transplant, 37%, 29%, 21%, 6% and 7% of patients were in CKD stage 1, 2, 3, 4, and 5, respectively with 95% of HCC patients in CKD stage 1, 2, or 3 vs. 82% of alcoholic and 85% of HCV patients. More severe CKD was significantly associated with increased risk of GF (Hazard ratio (HR) per unit increase = 1.13; 95% CI=1.11-1.16) regardless of diagnosis. Patients in CKD stage 2 or 3 who had a ≥1worsening in CKD stage by M12 had a significantly greater risk of GF at 4 years vs. patients who remained in their respective CKD stage (Table). Patients in CKD stage 1 who progressed to stage 2 or 3 at M12 were at decreased risk of GF (HR=0.64 and 0.76) vs. patients who remained at CKD stage 1 whereas patients who progressed to stage 4 or 5 were at increased risk of GF (HR=2.70 and 2.24). This result is independent of liver diagnosis (Stage by diagnosis 2-way interaction; p=0.588).

Conclusion: One stage worsening in CKD in the first 12 months is associated with a significantly increased risk of GF at 4 years. Poor prognosis for CKD stage 1 patients at M12 merits further investigation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Irish W, Massa P, Tran M, Bernhardt P, Ricci J. Association between Early Progression in Chronic Kidney Disease Stage Following Liver Transplantation and Graft Survival [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/association-between-early-progression-in-chronic-kidney-disease-stage-following-liver-transplantation-and-graft-survival/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences